Expanding access to gene therapies through novel cell lines and dPCR technologies

Jagadish Loganathan is a highly accomplished scientist responsible for establishing research and development operations at Agathos' Fargo, North Dakota facilities. He also takes the lead in managing both internal and external programs.

Before joining Agathos, Jagadish served as a Scientist at the Indiana University School of Medicine, where his research focused on studying the significance of correct compartmentalization of molecular signals mediated by natural compounds that target cancer genes. He has extensive scientific experience, including his role as a research associate at North Dakota State University (NDSU), where he specialized in targeting cancer cells in a hypoxic environment using nanoparticles. Additionally, during his time as a postdoctoral fellow at NDSU, Jagadish conducted research on the chemotherapeutic effects of plant-derived small molecules and lentiviral vectors on pancreatic and lung cancer cells.

Andrzej Noyszewski is a R&D Scientist who leads development and implementation of emerging technologies, analytical methods and insect cell culture development at Agathos Biologics. He holds a Doctor of Philosophy (PhD) in Genomics and Bioinformatics from North Dakota State University and a Master of Science and Engineering (MSc. Eng) in Biotechnology from Warsaw University of Life Sciences in Warsaw. His past work was related to cell wall metabolism, evolution of plants sexual reproduction, mitochondrial genomics, population genetics of invasive species, and work in method validation in GMP environment.

Mark Voight is the current Director of Business Development and Operations at Agathos Biologics. Mark holds a BS from North Dakota State University, Fargo, ND and an MBA from St. Cloud State University, St. Cloud, MN.